{"id":1418636,"title":"DSEN Abstract: Hydromorphone controlled release drug injection and hepatitis C virus (HCV), and human immunodeficiency virus (HIV) and infectious endocarditis (IE) infection - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-05-02","captureTimestamp":"2026-05-02T15:03:19.724000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53997.html","snippet":"DSEN Abstract Hydromorphone controlled release drug injection and hepatitis C virus (HCV), and human immunodeficiency virus (HIV) and infectious endocarditis (IE) infection Injecting oral hydromorphone can lead to serious infections. We observed a higher incidence of HCV…","rawSnapshotUrl":"/api/snapshots/raw/1418636","browseUrl":"https://replay.healtharchive.ca/job-8/20260502150319/https://cihr-irsc.gc.ca/e/53997.html#ha_snapshot=1418636","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}